Order Article Reprints

Faiella M, Botti G, Dalpiaz A, Gnudi L, Goyenvalle A, Pavan B, Perrone D, Bovolenta M, Marchesi E. In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment. Pharmaceutics. 2024; 16(8):1023. https://doi.org/10.3390/pharmaceutics16081023

Faiella, Marika, Giada Botti, Alessandro Dalpiaz, Lorenzo Gnudi, Aurélie Goyenvalle, Barbara Pavan, Daniela Perrone, Matteo Bovolenta, and Elena Marchesi. 2024. "In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment" Pharmaceutics 16, no. 8: 1023. https://doi.org/10.3390/pharmaceutics16081023

Faiella, M., Botti, G., Dalpiaz, A., Gnudi, L., Goyenvalle, A., Pavan, B., Perrone, D., Bovolenta, M., & Marchesi, E. (2024). In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment. Pharmaceutics, 16(8), 1023. https://doi.org/10.3390/pharmaceutics16081023